Prosecution Insights
Prosecution Insights
Technology area: Medical Devices & Mechanical Engineering
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
BIOGO CO., LTD. has 1 pending office action within the Medical Devices & Mechanical Engineering technology area. This activity is concentrated under 1 distinct examiner and 1 distinct art unit. This suggests that the company's current patenting efforts are directed toward a specific medical device or mechanical innovation. The presence of only 1 active matter indicates a focused and manageable prosecution workload.
The busiest examiner for this portfolio is WOZNICKI, JACQUELINE, who is responsible for 1 pending office action. This single action represents the total pending workload for the company. Because there is only 1 distinct examiner involved, the company's immediate patenting outcome is tied to the review of this one official. The involvement of only 1 distinct art unit further emphasizes the specialized nature of the pending application. Practitioners should be aware that the results of this 1 pending office action will have a significant impact on the company's current patent strategy. The lack of multiple examiners or art units simplifies the prosecution landscape but concentrates the risk on a single case.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| WOZNICKI, JACQUELINE | 1 | 49.8% | +26.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18254052 | COMPOSITION FOR PREPARING DECELLULARIZED SCAFFOLD, COMPRISING GRAPHENE NANOSTRUCTURE | WOZNICKI, JACQUELINE | 16d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18254052 | COMPOSITION FOR PREPARING DECELLULARIZED SCAFFOLD, COMPRISING GRAPHENE NANOSTRUCTURE | WOZNICKI, JACQUELINE | 16d |
| Art Unit | Apps |
|---|---|
| 3774 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18254052 | COMPOSITION FOR PREPARING DECELLULARIZED SCAFFOLD, COMPRISING GRAPHENE NANOSTRUCTURE | WOZNICKI, JACQUELINE | 3774 | §103§112 | Final Rejection | 16d | Pending | May 23, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial